Louisiana Challenges Nationwide Mifepristone Telemedicine Ban
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
“In emergency appeals filed Saturday, makers of Mifepristone, Danco Laboratories, and GenBioPro are asking the Supreme Court to restore mail order access.”
“In emergency appeals filed Saturday, makers of Mifeprixstone, Danco Laboratories, and GenBioPro are asking the Supreme Court to restore mail order access.”
“also used in miscarriage care. The ruling sent providers and patients scurrying.”
“the U.S. are prescribed via telehealth, and most abortions are from medication.”
“stay requested by Louisiana that affects the entire U.S., ruling the drug”
“The broadcast mentioned the appeal against the nationwide telemedicine ban for mifepristone.”
“Mifepristone Makers Appeal Nationwide Telemedicine Ban”
“Pharmaceutical Company Challenges Mifepristone Mail Ban”
“防止环境污染，行动就是未来。今年是155开局之年。全球目光集中中国高质量发展和技术创新。诺贝尔经济学奖获得者美国芝加哥大学 让他印象深刻。”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade